Public Profile

Eli Lilly and Company

Eli Lilly and Company, commonly referred to as Lilly, is a global leader in the pharmaceutical industry, headquartered in the United Kingdom. Founded in 1876, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative solutions in diabetes, oncology, immunology, and neuroscience. Lilly is renowned for its pioneering products, such as insulin therapies and cancer treatments, which are distinguished by their commitment to research and development. The company has achieved significant milestones, including the introduction of groundbreaking medications that have transformed patient care. With a robust market position, Eli Lilly continues to be recognised for its contributions to healthcare, consistently ranking among the top pharmaceutical companies worldwide.

DitchCarbon Score

How does Eli Lilly and Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

21

Industry Benchmark

Eli Lilly and Company's score of 36 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Eli Lilly and Company's reported carbon emissions

In 2023, Eli Lilly and Company reported total carbon emissions of approximately 5,139,500,000 kg CO2e, with emissions distributed across various scopes: 182,000,000 kg CO2e (Scope 1), 345,000,000 kg CO2e (Scope 2), and 5,139,500,000 kg CO2e (Scope 3). The company has made significant strides in reducing its carbon footprint, achieving a Scope 1 and 2 emissions total of about 527,000,000 kg CO2e. Eli Lilly's emissions data shows a commitment to transparency, with disclosures across all three scopes of emissions. However, there are currently no specific reduction targets or initiatives outlined in their climate commitments. The company continues to focus on sustainability practices, although detailed reduction initiatives have not been specified. Overall, Eli Lilly and Company is actively monitoring its carbon emissions and remains engaged in climate-related efforts, reflecting a growing awareness of environmental responsibility within the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2007200820092010201120122013201420192020202120222023
Scope 1
527,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,310,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
14,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Eli Lilly and Company's primary industry is Other services (93), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Eli Lilly and Company is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Eli Lilly and Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Novartis

CH
Chemicals nec
Updated about 3 hours ago

Wyeth LLC

US
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Abbvie

US
Chemicals nec
Updated 5 days ago

Bms

US
Chemicals nec
Updated about 3 hours ago

Schering-Plough Corporation

US
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Sanofi

FR
Chemicals nec
Updated about 2 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers